aluates Reports

$ 0.0

Automative

Global Personalized Tumor Vaccines Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-19W19260

BUY CHAPTERS

Global Personalized Tumor Vaccines Market Research Report 2025

Code: QYRE-Auto-19W19260

Report

April 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Personalized Tumor Vaccines Market Size

The global market for Personalized Tumor Vaccines was valued at US$ 148 million in the year 2024 and is projected to reach a revised size of US$ 231 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Personalized Tumor Vaccines Market

Personalized tumor vaccines are a type of customized immunotherapy based on a patient's individual tumor-specific antigens, designed to activate the patient's own immune system to accurately identify and attack tumor cells. Through genome sequencing and bioinformatics analysis, scientists are able to identify unique mutations (i.e., neoantigens) in tumor cells and design and synthesize vaccines targeting these neoantigens.

North American market for Personalized Tumor Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Personalized Tumor Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Personalized Tumor Vaccines in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Personalized Tumor Vaccines include Geneos Therapeutics, BioNTech, Siemens, Moderna, Merck, Everest Medicines, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Personalized Tumor Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Tumor Vaccines.

The Personalized Tumor Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Tumor Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Personalized Tumor Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Personalized Tumor Vaccines Market Report

Report Metric	Details
Report Name	Personalized Tumor Vaccines Market
Accounted market size in year	US$ 148 million
Forecasted market size in 2031	US$ 231 million
CAGR	6.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	DNA-based RNA-based
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Geneos Therapeutics, BioNTech, Siemens, Moderna, Merck, Everest Medicines
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Tumor Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Personalized Tumor Vaccines Market growing?

Ans: The Personalized Tumor Vaccines Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Personalized Tumor Vaccines Market size in 2031?

Ans: The Personalized Tumor Vaccines Market size in 2031 will be US$ 231 million.

Who are the main players in the Personalized Tumor Vaccines Market report?

Ans: The main players in the Personalized Tumor Vaccines Market are Geneos Therapeutics, BioNTech, Siemens, Moderna, Merck, Everest Medicines

What are the Application segmentation covered in the Personalized Tumor Vaccines Market report?

Ans: The Applications covered in the Personalized Tumor Vaccines Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Personalized Tumor Vaccines Market report?

Ans: The Types covered in the Personalized Tumor Vaccines Market report are DNA-based, RNA-based

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Personalized Tumor Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 DNA-based

1.2.3 RNA-based

1.3 Market by Application

1.3.1 Global Personalized Tumor Vaccines Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Personalized Tumor Vaccines Market Perspective (2020-2031)

2.2 Global Personalized Tumor Vaccines Growth Trends by Region

2.2.1 Global Personalized Tumor Vaccines Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Personalized Tumor Vaccines Historic Market Size by Region (2020-2025)

2.2.3 Personalized Tumor Vaccines Forecasted Market Size by Region (2026-2031)

2.3 Personalized Tumor Vaccines Market Dynamics

2.3.1 Personalized Tumor Vaccines Industry Trends

2.3.2 Personalized Tumor Vaccines Market Drivers

2.3.3 Personalized Tumor Vaccines Market Challenges

2.3.4 Personalized Tumor Vaccines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Personalized Tumor Vaccines Players by Revenue

3.1.1 Global Top Personalized Tumor Vaccines Players by Revenue (2020-2025)

3.1.2 Global Personalized Tumor Vaccines Revenue Market Share by Players (2020-2025)

3.2 Global Top Personalized Tumor Vaccines Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Personalized Tumor Vaccines Revenue

3.4 Global Personalized Tumor Vaccines Market Concentration Ratio

3.4.1 Global Personalized Tumor Vaccines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Personalized Tumor Vaccines Revenue in 2024

3.5 Global Key Players of Personalized Tumor Vaccines Head office and Area Served

3.6 Global Key Players of Personalized Tumor Vaccines, Product and Application

3.7 Global Key Players of Personalized Tumor Vaccines, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Tumor Vaccines Breakdown Data by Type

4.1 Global Personalized Tumor Vaccines Historic Market Size by Type (2020-2025)

4.2 Global Personalized Tumor Vaccines Forecasted Market Size by Type (2026-2031)

5 Personalized Tumor Vaccines Breakdown Data by Application

5.1 Global Personalized Tumor Vaccines Historic Market Size by Application (2020-2025)

5.2 Global Personalized Tumor Vaccines Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Personalized Tumor Vaccines Market Size (2020-2031)

6.2 North America Personalized Tumor Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Personalized Tumor Vaccines Market Size by Country (2020-2025)

6.4 North America Personalized Tumor Vaccines Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Personalized Tumor Vaccines Market Size (2020-2031)

7.2 Europe Personalized Tumor Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Personalized Tumor Vaccines Market Size by Country (2020-2025)

7.4 Europe Personalized Tumor Vaccines Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Personalized Tumor Vaccines Market Size (2020-2031)

8.2 Asia-Pacific Personalized Tumor Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Personalized Tumor Vaccines Market Size by Region (2020-2025)

8.4 Asia-Pacific Personalized Tumor Vaccines Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Personalized Tumor Vaccines Market Size (2020-2031)

9.2 Latin America Personalized Tumor Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Personalized Tumor Vaccines Market Size by Country (2020-2025)

9.4 Latin America Personalized Tumor Vaccines Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Personalized Tumor Vaccines Market Size (2020-2031)

10.2 Middle East & Africa Personalized Tumor Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Personalized Tumor Vaccines Market Size by Country (2020-2025)

10.4 Middle East & Africa Personalized Tumor Vaccines Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Geneos Therapeutics

11.1.1 Geneos Therapeutics Company Details

11.1.2 Geneos Therapeutics Business Overview

11.1.3 Geneos Therapeutics Personalized Tumor Vaccines Introduction

11.1.4 Geneos Therapeutics Revenue in Personalized Tumor Vaccines Business (2020-2025)

11.1.5 Geneos Therapeutics Recent Development

11.2 BioNTech

11.2.1 BioNTech Company Details

11.2.2 BioNTech Business Overview

11.2.3 BioNTech Personalized Tumor Vaccines Introduction

11.2.4 BioNTech Revenue in Personalized Tumor Vaccines Business (2020-2025)

11.2.5 BioNTech Recent Development

11.3 Siemens

11.3.1 Siemens Company Details

11.3.2 Siemens Business Overview

11.3.3 Siemens Personalized Tumor Vaccines Introduction

11.3.4 Siemens Revenue in Personalized Tumor Vaccines Business (2020-2025)

11.3.5 Siemens Recent Development

11.4 Moderna

11.4.1 Moderna Company Details

11.4.2 Moderna Business Overview

11.4.3 Moderna Personalized Tumor Vaccines Introduction

11.4.4 Moderna Revenue in Personalized Tumor Vaccines Business (2020-2025)

11.4.5 Moderna Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Personalized Tumor Vaccines Introduction

11.5.4 Merck Revenue in Personalized Tumor Vaccines Business (2020-2025)

11.5.5 Merck Recent Development

11.6 Everest Medicines

11.6.1 Everest Medicines Company Details

11.6.2 Everest Medicines Business Overview

11.6.3 Everest Medicines Personalized Tumor Vaccines Introduction

11.6.4 Everest Medicines Revenue in Personalized Tumor Vaccines Business (2020-2025)

11.6.5 Everest Medicines Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Personalized Tumor Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of DNA-based

Table 3. Key Players of RNA-based

Table 4. Global Personalized Tumor Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Personalized Tumor Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Personalized Tumor Vaccines Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Personalized Tumor Vaccines Market Share by Region (2020-2025)

Table 8. Global Personalized Tumor Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Personalized Tumor Vaccines Market Share by Region (2026-2031)

Table 10. Personalized Tumor Vaccines Market Trends

Table 11. Personalized Tumor Vaccines Market Drivers

Table 12. Personalized Tumor Vaccines Market Challenges

Table 13. Personalized Tumor Vaccines Market Restraints

Table 14. Global Personalized Tumor Vaccines Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Personalized Tumor Vaccines Market Share by Players (2020-2025)

Table 16. Global Top Personalized Tumor Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Tumor Vaccines as of 2024)

Table 17. Ranking of Global Top Personalized Tumor Vaccines Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Personalized Tumor Vaccines Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Personalized Tumor Vaccines, Headquarters and Area Served

Table 20. Global Key Players of Personalized Tumor Vaccines, Product and Application

Table 21. Global Key Players of Personalized Tumor Vaccines, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Personalized Tumor Vaccines Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Personalized Tumor Vaccines Revenue Market Share by Type (2020-2025)

Table 25. Global Personalized Tumor Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Personalized Tumor Vaccines Revenue Market Share by Type (2026-2031)

Table 27. Global Personalized Tumor Vaccines Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Personalized Tumor Vaccines Revenue Market Share by Application (2020-2025)

Table 29. Global Personalized Tumor Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Personalized Tumor Vaccines Revenue Market Share by Application (2026-2031)

Table 31. North America Personalized Tumor Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Personalized Tumor Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Personalized Tumor Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Personalized Tumor Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Personalized Tumor Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Personalized Tumor Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Personalized Tumor Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Personalized Tumor Vaccines Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Personalized Tumor Vaccines Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Personalized Tumor Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Personalized Tumor Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Personalized Tumor Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Personalized Tumor Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Personalized Tumor Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Personalized Tumor Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 46. Geneos Therapeutics Company Details

Table 47. Geneos Therapeutics Business Overview

Table 48. Geneos Therapeutics Personalized Tumor Vaccines Product

Table 49. Geneos Therapeutics Revenue in Personalized Tumor Vaccines Business (2020-2025) & (US$ Million)

Table 50. Geneos Therapeutics Recent Development

Table 51. BioNTech Company Details

Table 52. BioNTech Business Overview

Table 53. BioNTech Personalized Tumor Vaccines Product

Table 54. BioNTech Revenue in Personalized Tumor Vaccines Business (2020-2025) & (US$ Million)

Table 55. BioNTech Recent Development

Table 56. Siemens Company Details

Table 57. Siemens Business Overview

Table 58. Siemens Personalized Tumor Vaccines Product

Table 59. Siemens Revenue in Personalized Tumor Vaccines Business (2020-2025) & (US$ Million)

Table 60. Siemens Recent Development

Table 61. Moderna Company Details

Table 62. Moderna Business Overview

Table 63. Moderna Personalized Tumor Vaccines Product

Table 64. Moderna Revenue in Personalized Tumor Vaccines Business (2020-2025) & (US$ Million)

Table 65. Moderna Recent Development

Table 66. Merck Company Details

Table 67. Merck Business Overview

Table 68. Merck Personalized Tumor Vaccines Product

Table 69. Merck Revenue in Personalized Tumor Vaccines Business (2020-2025) & (US$ Million)

Table 70. Merck Recent Development

Table 71. Everest Medicines Company Details

Table 72. Everest Medicines Business Overview

Table 73. Everest Medicines Personalized Tumor Vaccines Product

Table 74. Everest Medicines Revenue in Personalized Tumor Vaccines Business (2020-2025) & (US$ Million)

Table 75. Everest Medicines Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. Personalized Tumor Vaccines Picture

Figure 2. Global Personalized Tumor Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Personalized Tumor Vaccines Market Share by Type: 2024 VS 2031

Figure 4. DNA-based Features

Figure 5. RNA-based Features

Figure 6. Global Personalized Tumor Vaccines Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Personalized Tumor Vaccines Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Personalized Tumor Vaccines Report Years Considered

Figure 12. Global Personalized Tumor Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Personalized Tumor Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Personalized Tumor Vaccines Market Share by Region: 2024 VS 2031

Figure 15. Global Personalized Tumor Vaccines Market Share by Players in 2024

Figure 16. Global Personalized Tumor Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Personalized Tumor Vaccines Revenue in 2024

Figure 18. North America Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Personalized Tumor Vaccines Market Share by Country (2020-2031)

Figure 20. United States Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Personalized Tumor Vaccines Market Share by Country (2020-2031)

Figure 24. Germany Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Personalized Tumor Vaccines Market Share by Region (2020-2031)

Figure 32. China Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Personalized Tumor Vaccines Market Share by Country (2020-2031)

Figure 40. Mexico Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Personalized Tumor Vaccines Market Share by Country (2020-2031)

Figure 44. Turkey Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Geneos Therapeutics Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 48. BioNTech Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 49. Siemens Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 50. Moderna Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 51. Merck Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 52. Everest Medicines Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global Tumor Specific Antigen Market Size Status and Forecast 2019 2025

Global Neoantigen Targeted Therapies Market Insights Forecast to 2030

Global Personalized Cancer Medicine Market Research Report 2025

Global Cancer Immunotherapy Drugs Market Research Report 2024

Global Neoantigen Targeted Therapy Market Research Report 2024

Peptide Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Personalized Cell Therapy Market Research Report 2024

Global Precision Cancer Medicine Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Peptide Based Vaccines for Cancer Market Research Report 2025

Global Targeted Cancer Therapy Market Research Report 2024

Global Personalized Precision Medicine Market Research Report 2024

Global Personalized Cancer Treatment Market Research Report 2025

Global Personalized Medicines In Oncology Market Research Report 2024

Global Dendritic Cell Vaccine Market Research Report 2025

Global Peptide Vaccine for Tumor Market Research Report 2024

Global Tumor Genomics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-13E17924

Fri Sep 26 00:00:00 UTC 2025

Add to Cart

Global Secondary Myelofibrosis Therapeutics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18R19870

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Personalized Tumor Vaccines Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-19W19260

Global Personalized Tumor Vaccines Market Research Report 2025

FEATURED COMPANIES

Personalized Tumor Vaccines Market Size

Personalized Tumor Vaccines Market

Scope of Personalized Tumor Vaccines Market Report

Chapter Outline

FAQ for this report

How fast is Personalized Tumor Vaccines Market growing?

What is the Personalized Tumor Vaccines Market size in 2031?

Who are the main players in the Personalized Tumor Vaccines Market report?

What are the Application segmentation covered in the Personalized Tumor Vaccines Market report?

What are the Type segmentation covered in the Personalized Tumor Vaccines Market report?

FEATURED COMPANIES

RELATED REPORTS